Treatment of carbapenem-resistant

Anti-Bacterial Agents / pharmacology Carbapenems / pharmacology Cephalosporins / pharmacology Humans Microbial Sensitivity Tests Pseudomonas Infections / drug therapy Pseudomonas aeruginosa beta-Lactamase Inhibitors / therapeutic use Cefiderocol
Beta-lactam–beta-lactamase inhibitor CR Pseudomonas aeruginosa carbapenem resistance cefiderocol cephalosporin siderophores susceptibility

Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 4 5 2022
medline: 30 7 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

Carbapenem-resistant (CR) This article reviews the mechanisms of Cefiderocol is active against most known

Identifiants

DOI: 10.1080/14787210.2022.2071701 PMID: 35502603
pubmed: 35502603
doi: 10.1080/14787210.2022.2071701
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
Cephalosporins 0
beta-Lactamase Inhibitors 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1077-1094

Auteurs

Rafael Canton (R)

Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.

Yohei Doi (Y)

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Patricia J Simner (PJ)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Treatment of carbapenem-resistant
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Treatment of carbapenem-resistant
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Treatment of carbapenem-resistant
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Treatment of carbapenem-resistant
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Treatment of carbapenem-resistant
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Pseudomonas › Treatment of carbapenem-resistant
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Pseudomonadaceae › Pseudomonas › Pseudomonas aeruginosa › Treatment of carbapenem-resistant
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Inhibiteurs des bêta-lactamases › Treatment of carbapenem-resistant